Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
4.300
+0.280 (6.97%)
At close: Nov 28, 2025, 1:00 PM EST
4.350
+0.050 (1.16%)
After-hours: Nov 28, 2025, 4:58 PM EST

Sana Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-234.41-266.76-283.26-269.48-355.93-285.31
Upgrade
Depreciation & Amortization
13.515.517.5415.6311.075.92
Upgrade
Asset Writedown & Restructuring Costs
46.51.897.01---
Upgrade
Stock-Based Compensation
25.5637.6835.5338.3422.365.83
Upgrade
Other Operating Activities
-0.25-10.28-49.03-82.0861.64129.42
Upgrade
Change in Accounts Payable
-1.081.381.031.06-0.271.98
Upgrade
Change in Other Net Operating Assets
-8.18-2.5617.586.4810.074.17
Upgrade
Operating Cash Flow
-158.35-223.15-253.58-290.05-251.05-137.98
Upgrade
Capital Expenditures
-0.5-33.43-20.03-20.88-29.86-23.87
Upgrade
Investment in Securities
23.0850.88192.04231.44-211.36-228.69
Upgrade
Other Investing Activities
-----4.57-
Upgrade
Investing Cash Flow
23.3517.45172.01210.56-245.8-252.56
Upgrade
Long-Term Debt Issued
-7.74----
Upgrade
Net Debt Issued (Repaid)
-0.317.74----
Upgrade
Issuance of Common Stock
112.04192.0131.654.91631.750.15
Upgrade
Financing Cash Flow
111.73199.7531.654.91631.75435.69
Upgrade
Net Cash Flow
-23.28-5.95-49.92-74.58134.945.14
Upgrade
Free Cash Flow
-158.85-256.58-273.61-310.93-280.92-161.85
Upgrade
Free Cash Flow Per Share
-0.65-1.11-1.41-1.65-1.69-12.44
Upgrade
Levered Free Cash Flow
-93.53-168.6-206.93-140.89-138.16-166.01
Upgrade
Unlevered Free Cash Flow
-93.53-168.6-206.93-140.89-138.16-166.01
Upgrade
Change in Working Capital
-9.26-1.1918.617.549.86.16
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q